TXN, PWRM, AMB, UIS - Stock-PR.com Stock Report! March 25th 2011

FREE Daily Stock Alerts From Stock-PR.com

Texas Instruments Inc. (NYSE:TXN) introduced the industry’s most power-efficient 4-channel, 16-bit DAC (digital-to-analog converter). At 1.25 GSPS, the DAC3484 is 25 percent faster than the next fastest quad DAC while consuming as little as 250 mW per channel – 65 percent less than the closest competitor. The DAC3484 is also 40 percent smaller than alternative quad DAC solutions while enabling wideband power amplifier linearization of up to 250 MHz. The wider input bus DAC34H84 or the 2-channel DAC3482 are available to support a linearization bandwidth up to 500 MHz.

Texas Instruments Incorporated engages in the design and sale of semiconductors to electronics designers and manufacturers worldwide. It has a collaboration agreement with Gemalto NV. The company was founded in 1938 and is headquartered in Dallas, Texas.

~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~

Power3 Medical Products, Inc. (OTCBB:PWRM.OB), is a leading bio-technology company focused on the development of innovative diagnostic tests in the fields of cancer and neurodegenerative diseases such as Alzheimer’s disease, Parkinson’s disease and amyotrophic lateral sclerosis (commonly known as ALS or Lou Gehrig’s disease). Power3 applies proprietary methodologies to discover and identify protein biomarkers associated with diseases. Through these processes, Power3 has developed a portfolio of products including BC-SeraPro™, a proteomic blood serum test for the early detection of breast cancer for which it has completed Phase I clinical trials, and NuroPro®, a proteomic blood serum test for the detection of neurodegenerative diseases, including Alzheimer’s, Parkinson’s, and ALS diseases, for which it is currently engaged in Phase II clinical trials. These tests are designed to analyze an individual’s proteins to detect the presence of disease, a patient’s disease progression, a patient’s response to a particular drug, and the mechanisms of disease present in the patient for optimal targeted therapy.

PWRM has big plans for the future beginning with its upcoming acquisition of Rozetta-Cell and are about to enter a long and substantial growth phase marked by advances in its science and intellectual property.

Rozetta-Cell is a medical biotechnology company that focuses on the delivery and imaging of stem cells during therapy. The company has a robust intellectual property portfolio and has created numerous products for adult stem cell therapy that are ready for market globally. Rozetta-Cell also has several collaborations in process through which it is partnering with industry-leading adult stem cell research companies and adult stem cell vendors.

PWRM plans to effect the acquisition of Rozetta-Cell by merging Rozetta-Cell with and into Power3, with Power3 remaining as the surviving company.

More:

PWRM recently announced that company management believes it is making great progress in its focus on the development, sales, and marketing of its proprietary innovate diagnostic tests for breast cancer, pancreatic cancer, ovarian cancer, colon cancer, and certain neurodegenerative diseases, such as Alzheimer’s and Parkinson’s, to name a few.

PWRM strives to become the premier biotechnology company specializing in the commercialization of proteomics IP for the diagnosis and treatment of disease by using cutting edge technologies, world class quality procedures and superior research methodologies. The Company will be guided in all of its dealings with its customers, partners, shareholders, associates and investors by the philosophy of best practices.

More about PWRM at: www.Power3Medical.com

~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~

Unisys Corporation (NYSE:UIS) announced its Unisys Hybrid Enterprise framework, a comprehensive methodology and set of services for helping organizations manage multiple IT delivery models – both traditional and cloud-based – within a consistent computing environment managed as a single entity.

Unisys Corporation operates as an information technology (IT) company worldwide. The company operates in two segments, Services and Technology. The company was founded in 1886 and is based in Blue Bell, Pennsylvania.

~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~

AMB Property Corp. (NYSE:AMB) announced its first quarter 2011 earnings on Wednesday, April 20, 2011, prior to the market opening. The company will then host a conference call to discuss the quarterly results at 1:00 PM EDT/10:00 AM PDT. To access a live broadcast of the conference call, dial 877 256 7020 (from the U.S. and Canada) or +1 706 643 7823 (from all other countries) and enter reservation code 54105336. You may also access the live webcast of the conference call from the company’s website in the Investor Relations section.

AMB Property Corporation engages in the acquisition, development, and operation of industrial properties in North America, Europe, and Asia. AMB Property was founded in 1983 and is headquartered in San Francisco, California.

**************************************************************

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!